Related Experiment Video
Updated: Jun 10, 2026
Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma
Forrest M Kievit1, Omid Veiseh, Chen Fang
1Department of Materials Science and Engineering, University of Washington, Seattle, Washington 98195, USA.
Abstract:
Glioma accounts for 80% of brain tumors and currently remains one of the most lethal forms of cancers. Gene therapy could potentially improve the dismal prognosis of patients with glioma, but this treatment modality has not yet reached the bedside from the laboratory due to the lack of safe and effective gene delivery vehicles. In this study we investigate targeted gene delivery to C6 glioma cells in a xenograft mouse model using chlorotoxin (CTX) labeled nanoparticles. The developed nanovector consists of an iron oxide nanoparticle core, coated with a copolymer of chitosan, polyethylene glycol (PEG), and polyethylenimine (PEI). Green fluorescent protein (GFP) encoding DNA was bound to these nanoparticles, and CTX was then attached using a short PEG linker. Nanoparticles without CTX were also prepared as a control. Mice bearing C6 xenograft tumors were injected intravenously with the DNA-bound nanoparticles. Nanoparticle accumulation in the tumor site was monitored using magnetic resonance imaging and analyzed by histology, and GFP gene expression was monitored through Xenogen IVIS fluorescence imaging and confocal fluorescence microscopy. Interestingly, the CTX did not affect the accumulation of nanoparticles at the tumor site but specifically enhanced their uptake into cancer cells as evidenced by higher gene expression. These results indicate that this targeted gene delivery system may potentially improve treatment outcome of gene therapy for glioma and other deadly cancers.
Insights
Targeted nanoparticles carrying therapeutic DNA show promise for glioma treatment. Chlorotoxin (CTX) enhanced cancer cell uptake, improving gene delivery for potential brain tumor therapies.
Area of Science:
- Neuro-oncology
- Nanomedicine
- Biotechnology
Background:
- Glioma is a lethal brain cancer with poor prognosis.
- Effective gene delivery vehicles are crucial for advancing glioma gene therapy.
- Current gene therapy approaches face challenges in safe and targeted delivery.
Purpose of the Study:
- To investigate targeted gene delivery to C6 glioma cells using chlorotoxin (CTX)-labeled nanoparticles.
- To develop and evaluate a novel nanovector for glioma gene therapy.
- To assess the efficacy of CTX-mediated targeting in enhancing gene expression within tumor cells.
Main Methods:
- Fabrication of iron oxide nanoparticles coated with chitosan, polyethylene glycol (PEG), and polyethylenimine (PEI).
- Conjugation of green fluorescent protein (GFP) DNA and CTX to the nanoparticles.
- Intravenous injection of nanoparticles into a C6 glioma xenograft mouse model.
- Monitoring nanoparticle accumulation via MRI and histology; assessing gene expression using fluorescence imaging and microscopy.
Main Results:
- CTX-labeled nanoparticles demonstrated enhanced uptake into glioma cells compared to unlabeled nanoparticles.
- Nanoparticle accumulation at the tumor site was not significantly affected by CTX.
- Increased GFP gene expression was observed in CTX-targeted tumors, indicating successful gene delivery.
- Histological and imaging analyses confirmed targeted delivery and cellular uptake.
Conclusions:
- The developed CTX-labeled nanoparticle system facilitates targeted gene delivery to glioma cells.
- This targeted approach shows potential for improving the efficacy of gene therapy for brain tumors.
- Further research into this nanovector could lead to improved treatment outcomes for glioma patients.
